<SEC-DOCUMENT>0000905148-26-001247.txt : 20260313
<SEC-HEADER>0000905148-26-001247.hdr.sgml : 20260313
<ACCEPTANCE-DATETIME>20260313161130
ACCESSION NUMBER:		0000905148-26-001247
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20260213
FILED AS OF DATE:		20260313
DATE AS OF CHANGE:		20260313

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Urban Michael J.
		CENTRAL INDEX KEY:			0002118666
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40366
		FILM NUMBER:		26752535

	MAIL ADDRESS:	
		STREET 1:		200 TALCOTT AVE.
		STREET 2:		2ND FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Werewolf Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001785530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				823523180
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 TALCOTT AVENUE
		STREET 2:		2ND FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-952-0555

	MAIL ADDRESS:	
		STREET 1:		200 TALCOTT AVENUE
		STREET 2:		2ND FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2026-02-13</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001785530</issuerCik>
        <issuerName>Werewolf Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>HOWL</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002118666</rptOwnerCik>
            <rptOwnerName>Urban Michael J.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O WEREWOLF THERAPEUTICS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>200 TALCOTT AVENUE, 2ND FLOOR</rptOwnerStreet2>
            <rptOwnerCity>WATERTOWN</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02472</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>false</isDirector>
            <isOfficer>true</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
            <officerTitle>VP of Finance &amp; Corp. Contr.</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>5284</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.65</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2033-05-31</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>52500</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>4.64</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2034-01-01</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>29365</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.57</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2034-12-18</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>10000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.56</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <value>2035-01-01</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>54800</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option was granted on June 1, 2023. The shares underlying the option vested as to 25% on May 15, 2024, and the remainder vest in substantially equal monthly installments thereafter through May 15, 2027.</footnote>
        <footnote id="F2">The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.</footnote>
        <footnote id="F3">The option was granted on December 19, 2024, and is fully vested.</footnote>
        <footnote id="F4">The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.</footnote>
    </footnotes>

    <remarks>Exhibit List: Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Jonathan Owen, Attorney-in-fact</signatureName>
        <signatureDate>2026-03-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>poa_urban.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<!-- Created by CompSci Resources, LLC on Fri Mar 13 15:19:05 UTC 2026 --><html>
 <head><meta content="text/html; charset=ASCII">
  <title></title>
 </head>
 <body style="font-family: Arial; font-size: 10.5pt; width: 468.0pt;">
  <div style="margin-bottom: 10.5pt; line-height: 13.2pt; text-align: center;">
   <font style="font-family: Times New Roman; font-size: 11.0pt; font-weight: bold;">POWER OF ATTORNEY</font>
  </div>
  <div style="margin-bottom: 10.5pt; line-height: 13.2pt; text-align: justify;">
   <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">The undersigned hereby makes, constitutes and appoints each of Daniel J. Hicklin and Jonathan Owen, or either of them acting singly, and with full power of substitution, re-substitution and delegation, the undersigned&#x2019;s true and lawful attorney&#x2011;in&#x2011;fact (each of such persons and their substitutes and delegees being referred to herein as the "Attorney-in-Fact"), with full power to act for the undersigned and in the undersigned's name, place and stead, in the undersigned&#x2019;s capacity as an officer, director or stockholder of Werewolf Therapeutics, Inc. (the &#x201c;Company&#x201d;), to:</font>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 18.0pt; font-family: Times New Roman; font-size: 11pt;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">1.</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt; color: #000000;">Take such actions as may be necessary or appropriate to </font><font style="font-size: 11.0pt;">enable the undersigned to submit and file forms, schedules and other documents with the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) utilizing the SEC&#x2019;s Electronic Data Gathering and Retrieval (&#x201c;EDGAR&#x201d;) system, which actions may include (a) enrolling the undersigned in EDGAR Next and (b) preparing, executing and submitting to the SEC</font><font style="font-size: 11.0pt; color: #000000;">&#xa0;a Form ID, amendments thereto, and such other documents and information as may be necessary or appropriate to obtain codes and passwords enabling the undersigned to make filings and submissions utilizing the EDGAR system;</font>
    </div>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 18.0pt; font-family: Times New Roman; font-size: 11pt; clear: both;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">2.</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt; color: #000000;">Prepare and execute any and all forms, schedules and other documents (including any amendments thereto) the undersigned is required to file with the SEC, or which the Attorney-in-Fact considers it advisable for the undersigned to file with the SEC, under Section 13 or Section 16 of the Securities Exchange Act of 1934 or any rule or regulation thereunder, or under Rule 144 under the Securities Act of 1933 (&#x201c;Rule 144&#x201d;), including Forms 3, 4 and 5, Schedules 13D and 13G, and Forms 144 (all such forms, schedules and other documents being referred to herein as &#x201c;SEC Filings&#x201d;);</font>
    </div>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 18.0pt; font-family: Times New Roman; font-size: 11pt; clear: both;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">3.</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt; color: #000000;">Submit and file SEC Filings with the SEC utilizing the EDGAR system or cause them to be submitted and filed by a person appointed under </font><font style="font-size: 11.0pt; color: #000000; text-decoration: underline;">Section 5</font><font style="font-size: 11.0pt; color: #000000;"> below;</font>
    </div>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 18.0pt; font-family: Times New Roman; font-size: 11pt; clear: both;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">4.</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt; color: #000000;">File, submit or otherwise deliver SEC Filings to any securities exchange on which the Company&#x2019;s securities may be listed or traded;</font>
    </div>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 18.0pt; font-family: Times New Roman; font-size: 11pt; clear: both;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">5.</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt; color: #000000;">Act as an account administrator for the undersigned&#x2019;s EDGAR account, including: </font><font style="font-size: 11.0pt;">(i) appoint, remove and replace account administrators, account users, technical administrators and delegated entities; (ii) maintain the security of the undersigned&#x2019;s EDGAR account, including modification of access codes; (iii) maintain, modify and certify the accuracy of information on the undersigned&#x2019;s EDGAR account dashboard; (iv) act as the EDGAR point of contact with respect to the undersigned&#x2019;s EDGAR account; and (v) any other actions contemplated by Rule 10 of Regulation S-T with respect to account administrators. </font>
    </div>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 18.0pt; font-family: Times New Roman; font-size: 11pt; clear: both;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">6.</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt;">Cause the Company to accept a delegation of authority from any of the undersigned&#x2019;s EDGAR account administrators and, pursuant to that delegation, authorize the Company&#x2019;s EDGAR account administrators to appoint, remove or replace users for the undersigned&#x2019;s EDGAR account; and</font>
    </div>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 18.0pt; font-family: Times New Roman; font-size: 11pt; clear: both;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">7.</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt; color: #000000;">Obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.</font>
    </div>
  </div>
  <div style="text-indent: 45.8pt; margin-bottom: 10.5pt; line-height: 13.2pt; text-align: justify; clear: both;">
   <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">The undersigned acknowledges that:</font>
  </div>
  <div style="margin-bottom: 12pt; text-align: justify; margin-left: 45.8pt; font-family: Times New Roman; font-size: 11pt;">
    <div style="float: left; text-align: right;">
     <font style="font-size: 11.0pt; min-width: 18.0pt; display: inline-block; text-align: left;">a)</font>
    </div>
    <div style="margin-left: 18.0pt;">
     <font style="font-size: 11.0pt; color: #000000;">This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;</font>
    </div>
  </div>
  <div style="text-indent: -18pt; margin-bottom: 12pt; text-align: justify; padding-left: 63.8pt; clear: both;">
    <div style="float: left; width: 18.0pt; white-space: nowrap;">
     <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">b)</font>
    </div>
    <div>
     <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;</font>
    </div>
  </div>
  <div style="text-indent: -18pt; margin-bottom: 12pt; text-align: justify; padding-left: 63.8pt; clear: both;">
    <div style="float: left; width: 18.0pt; white-space: nowrap;">
     <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">c)</font>
    </div>
    <div>
     <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 13 or Section 16 of the Exchange Act or Rule 144, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and</font>
    </div>
  </div>
  <div style="text-indent: -18pt; margin-bottom: 12pt; text-align: justify; padding-left: 63.8pt; clear: both;">
    <div style="float: left; width: 18.0pt; white-space: nowrap;">
     <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">d)</font>
    </div>
    <div>
     <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 13 or Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 13 or Section 16 of the Exchange Act.</font>
    </div>
  </div>
  <div style="text-indent: 45.8pt; margin-bottom: 10.5pt; line-height: 13.2pt; text-align: justify; clear: both;">
   <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">The undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform each and every act and thing requisite, necessary or advisable to be done in connection with the foregoing, as fully, to all intents and purposes, as the undersigned might or could do in person, hereby ratifying and confirming all that the Attorney-in-Fact, or his or her substitute or substitutes, shall lawfully do or cause to be done by authority of this Power of Attorney.</font>
  </div>
  <div style="text-indent: 45.8pt; margin-bottom: 10.5pt; line-height: 13.2pt; text-align: justify;">
   <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 or 5 or Schedules 13D or 13G or Forms 144 with respect to the undersigned's holdings of and transactions in securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Attorney-in-Fact. This Power of Attorney revokes all previous powers of attorney with respect to the subject matter of this Power of Attorney.</font>
  </div>
  <div style="text-indent: 45.8pt; margin-bottom: 10.5pt; line-height: 13.2pt; text-align: justify;">
   <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 13, 2026.</font>
  </div>
  <div style="text-indent: 252pt; text-align: justify;">
   <font style="font-family: Times New Roman; font-size: 11.0pt; color: #000000;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</font>
  </div>
  <div style="margin-left: 216pt;">
    <div style="float: left; width: 108.0pt; white-space: nowrap;">
     <font style="font-family: Times New Roman; font-size: 11.0pt; text-decoration: underline;">/s/ Michael J. Urban</font>
    </div>
    <div>
     <font style="font-family: Times New Roman; font-size: 11.0pt; text-decoration: underline;">&#xa0;</font>
    </div>
  </div>
  <div style="margin-left: 216pt; clear: both;">
   <font style="font-family: Times New Roman; font-size: 11.0pt;">Signature</font>
  </div>
  <div style="margin-left: 216pt; font-size: 11pt;">&#xa0;
  </div>
  <div style="margin-left: 216pt;">
    <div style="float: left; width: 108.0pt; white-space: nowrap;">
     <font style="font-family: Times New Roman; font-size: 11.0pt; text-decoration: underline;">Michael J. Urban</font>
    </div>
    <div>
     <font style="font-family: Times New Roman; font-size: 11.0pt; text-decoration: underline;">&#xa0;</font>
    </div>
  </div>
  <div style="margin-left: 216pt; clear: both;">
   <font style="font-family: Times New Roman; font-size: 11.0pt;">Print Name</font>
  </div>
 </body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
